Search papers, labs, and topics across Lattice.
This study assessed the perspectives of European policymakers and cancer patients on the role of telemedicine in cancer care. The study used a mixed-methods approach, including surveys and a workshop, to gather insights from decision-makers in 14 EU Member States and eight cancer patient associations. The findings suggest that telemedicine is viewed as a useful adjunct to, but not a replacement for, in-person cancer care, highlighting the need for legal frameworks, improved digital literacy, and patient engagement in telemedicine service design.
Telemedicine is viewed as a useful adjunct to in-person cancer care in Europe, but not a replacement, emphasizing the need for supportive legal frameworks and improved digital literacy.
Telemedicine is increasingly playing a vital role in European health systems, offering great potential for improving healthcare access and outcomes. Funded between September 2022 and December 2024, the Joint Action 'Strengthening eHealth including telemedicine and remote monitoring for health care systems for CANcer prevention and care' (eCAN JA) provided evidence-base for person-centred implementation of telemedicine services among cancer patients in the European Union (EU). Through a mixed-method approach, this foresight study gathered insights from key decision-makers in 14 EU Member States and eight cancer patient associations via two surveys and a joint workshop, conducted within the Sustainability Work Package (WP4) of the eCAN JA. Our results show that EU Member States and cancer patients view telemedicine as a useful and complementary tool, however, not as a replacement for in-person services for cancer care. The policy recommendations from our study can be summarised as follows: (i) develop legal frameworks to complement in-person care with telemedicine; (ii) improve digital literacy and information technology infrastructure while ensuring privacy and health equity; and (iii) engage patients in the co-design of telemedicine services. Implementing these recommendations will enhance the integration of telemedicine into cancer care in Europe.
